Snapdragon Chemistry and Johnson Matthey Collaborate to Bring Effective Continuous Manufacturing Solutions to Pharma and Biotech

Snapdragon Chemistry Inc., a leader in flow chemistry process design and technology development, and Johnson Matthey (LSE: JMAT), a global leader in science that enables cleaner air, improved health and more efficient use of natural resources, are pleased to announce that they have entered in to a collaborative agreement to provide integrated continuous manufacturing services – from development to full-scale GMP manufacturing.

Continuous flow chemistry can transform pharmaceutical manufacturing processes by reducing the number of synthetic steps while increasing yield, enhancing purity and providing more effective quality controls, resulting in reduced capital expenditure and increased speed to market. Yet the pharmaceutical and biotech industries have yet to fully adopt this transformational technology. The collaboration between Johnson Matthey (JM) and Snapdragon Chemistry will address this by creating a complete and powerful end-to-end offering that can provide the full scope of process development and manufacturing services, from flow chemistry route conception to cGMP bulk production.

The agreement combines Snapdragon Chemistry’s cutting-edge flow chemistry design, development and characterisation capabilities with JM’s offering in clinical to commercial API development and manufacturing, which includes considerable quality systems infrastructure, together with JM’s expertise in continuous manufacturing processes.

“Snapdragon has outstanding skills, capabilities and people for the development of continuous flow chemistry,” commented Robert MacLeod, Chief Executive of JM. “With this collaboration we will be able to unlock significant value for customers through the rapid development of more efficient, sustainable and robust manufacturing processes.”

“We are delighted to be partnering with JM,” said Matthew Bio, President and CEO Snapdragon Chemistry. “They are a leading provider of API development and manufacturing services and we share similar passions for innovation and delivery of quality science, engineering and materials to our clients.”

The two companies have co-located facilities in the Boston area, allowing joint Snapdragon Chemistry and JM teams to interact closely to both develop flow chemistry processes and scale those processes through to manufacturing. This will allow clients to take full advantage of continuous manufacturing technology throughout the drug development life cycle.

About Snapdragon Chemistry, Inc.
Snapdragon Chemistry is a privately held company based in Cambridge, MA. Snapdragon was founded in 2014 as a contract research organization with the mission to deliver advanced continuous manufacturing technology solutions for innovators in the pharmaceutical, fine chemical and materials industries. Snapdragon is investing in the development of new technologies to automate flow chemical process development to deliver clients dramatically reduced timelines, enable rapid scale-up of flow processes and ensure consistent product quality across the continuum from milligrams to kilograms.

About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200-years of sustained commitment to innovation and technological breakthroughs that improve the function, performance and safety of our customer’s products. Our science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with our network of customers and partners to make a real difference to the world around us. For more information, visit matthey.comInspiring science, enhancing life